Guides
Bringing family or a carer
A companion can help with communication and logistics, but their role, access and costs should be agreed before travel. They do not replace clinical staff or informed consent.
Ask the provider whether a companion may attend consultations, remain during observation or stay overnight. Facility policy, privacy and infection-control requirements may limit access at different stages.
Choose the companion for reliability, communication and ability to follow the contingency plan, not as a clinical decision-maker by default. Record who may receive information and who may act only if you lose capacity.
Consent remains the patient's decision when the patient has capacity. A companion may help ask questions or take notes, but the clinician must speak to the patient in understandable language and use qualified interpretation where needed.
Give the companion a concise pack: facility address, responsible clinician, medicines, allergies, relevant diagnoses, insurance details, emergency contacts and the agreed escalation route. Avoid giving unnecessary access to the full record.
Clarify practical support after discharge, including transport, meals, mobility, medicines and communication. Do not assume the companion is trained to monitor a procedure or manage a complication.
If a child or dependent adult travels, check safeguarding, consent, accommodation and supervision requirements with the provider and carrier. The proposed intervention should also have age-appropriate specialist review and authorisation.
Budget the companion's travel, accommodation, meals, insurance, lost work and possible extended stay separately. Ask whether any sponsor, insurer or public scheme covers those costs; do not infer coverage from the treatment quote.
Agree what happens if the companion becomes ill or must leave. Keep an alternative contact, accessible transport option and enough flexibility to extend the stay without relying on clinic sales staff.
Use the cost worksheet, then verify the exact product, evidence, legal route and written quotation with an independent qualified clinician.
Sources & further reading
- Stem-cell trials registry (ClinicalTrials.gov) ↗
- Peer-reviewed research (PubMed) ↗
- ISSCR — patient resources ↗
- FDA — consumer guidance ↗
- EMA — ATMP framework ↗
Educational guide; most uses are investigational. Verify the exact product, indication and provider with current regulator records and an independent qualified physician.